Literature DB >> 19416693

Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials.

Hajime J Yuasa1, Helen J Ball, Yuen Fern Ho, Christopher J D Austin, Camilla M Whittington, Katherine Belov, Ghassan J Maghzal, Lars S Jermiin, Nicholas H Hunt.   

Abstract

Indoleamine 2,3-dioxygenase (IDO1) and tryptophan 2,3-dioxygenase (TDO) are tryptophan-degrading enzymes that catalyze the first step in tryptophan catabolism via the kynurenine pathway. TDO is widely distributed in both eukaryotes and bacteria. In contrast, IDO has been found only in mammals and yeast. In 2007, a third enzyme, indoleamine 2,3-dioxygenase-2 (IDO2), was discovered. IDO2 is found not only in mammals but also in lower vertebrates. Interestingly, the K(m) value of IDO2 for L-Trp was 500-1000 fold higher than that of IDO1. In this study, we isolated both IDO1 and IDO2 cDNA from a monotreme, the platypus (Ornithorhynchus anatinus), and a marsupial, the gray short-tailed opossum (Monodelphis domestica). We characterized the recombinant proteins and those of other known IDO1/IDO2 in intact cells and a cell-free system. It was found that methylene blue may not be suitable reductant for IDO2, hence resulting in an underestimation of recombinant IDO2 activity. In intact cells, the K(m) value of IDO2 for L-Trp was estimated to be much higher than that of IDO1 and this high K(m) value appears to have been conserved during the evolution of IDO2. The protein encoded by the ancestor gene of IDO1 and IDO2 is likely to have had properties more similar to present day IDO2 than to IDO1.

Entities:  

Year:  2009        PMID: 19416693     DOI: 10.1016/j.cbpb.2009.02.002

Source DB:  PubMed          Journal:  Comp Biochem Physiol B Biochem Mol Biol        ISSN: 1096-4959            Impact factor:   2.231


  16 in total

1.  Molecular evolution and characterization of fungal indoleamine 2,3-dioxygenases.

Authors:  Hajime J Yuasa; Helen J Ball
Journal:  J Mol Evol       Date:  2010-12-18       Impact factor: 2.395

2.  Benzo[b]quinolizinium Derivatives Have a Strong Antimalarial Activity and Inhibit Indoleamine Dioxygenase.

Authors:  Esther Jortzik; Kathleen Zocher; Antje Isernhagen; Boniface M Mailu; Stefan Rahlfs; Giampietro Viola; Sergio Wittlin; Nicholas H Hunt; Heiko Ihmels; Katja Becker
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

Review 3.  The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity.

Authors:  Jacques C Mbongue; Dequina A Nicholas; Timothy W Torrez; Nan-Sun Kim; Anthony F Firek; William H R Langridge
Journal:  Vaccines (Basel)       Date:  2015-09-10

Review 4.  IDO2 in Immunomodulation and Autoimmune Disease.

Authors:  George C Prendergast; Richard Metz; Alexander J Muller; Lauren M F Merlo; Laura Mandik-Nayak
Journal:  Front Immunol       Date:  2014-11-20       Impact factor: 7.561

Review 5.  Tryptophan-degrading enzymes in tumoral immune resistance.

Authors:  Nicolas van Baren; Benoît J Van den Eynde
Journal:  Front Immunol       Date:  2015-02-03       Impact factor: 7.561

6.  Inhibition of the BET family reduces its new target gene IDO1 expression and the production of L-kynurenine.

Authors:  Chang-Qing Tian; Lin Chen; Hua-Dong Chen; Xia-Juan Huan; Jian-Ping Hu; Jing-Kang Shen; Bing Xiong; Ying-Qing Wang; Ze-Hong Miao
Journal:  Cell Death Dis       Date:  2019-07-19       Impact factor: 8.469

Review 7.  IDO1 in cancer: a Gemini of immune checkpoints.

Authors:  Lijie Zhai; Erik Ladomersky; Alicia Lenzen; Brenda Nguyen; Ricky Patel; Kristen L Lauing; Meijing Wu; Derek A Wainwright
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

8.  Indoleamine 2,3-Dioxygenase 2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation.

Authors:  Kento Fujii; Yasuko Yamamoto; Yoko Mizutani; Kuniaki Saito; Mariko Seishima
Journal:  Int J Mol Sci       Date:  2020-08-01       Impact factor: 5.923

9.  Lipopolysaccharide shock reveals the immune function of indoleamine 2,3-dioxygenase 2 through the regulation of IL-6/stat3 signalling.

Authors:  Yasuko Yamamoto; Wakana Yamasuge; Shinjiro Imai; Kazuo Kunisawa; Masato Hoshi; Hidetsugu Fujigaki; Akihiro Mouri; Toshitaka Nabeshima; Kuniaki Saito
Journal:  Sci Rep       Date:  2018-10-29       Impact factor: 4.379

10.  Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD+ Synthesis During Inflammation and Infection.

Authors:  John R Moffett; Peethambaran Arun; Narayanan Puthillathu; Ranjini Vengilote; John A Ives; Abdulla A-B Badawy; Aryan M Namboodiri
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.